Share of consumption of biosimilar drugs in Italy 2016-2023

Published by
Juliette Gagliardi,
Sep 3, 2024

Between 2016 and 2023, the share of biosimilars consumed out of the total marketed molecules for which the biosimilar variation was available, increased from 13 to 49 percent. Biosimilars are drugs of biological origin which are very similar in function and effect to previously approved biological products. This statistic shows the share of consumption of biosimilar drugs in Italy from 2016 to 2023.

Share of consumption of biosimilar drugs in Italy from 2016 to 2023

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2024

Region

Italy

Survey time period

2016 to 2023

Supplementary notes

Share of consumption of biosimilar drugs out of total marketed molecules for which is available the biosimilar variation.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Generics and biosimilars in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars in Italy

Global overview

5

Generic drugs overview

7

Generics' expenditure

5

Generics' consumption

3

Biosimilar drugs

5

Outlook

5

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilars in ItalyTop pharmaceutical drugsHealth and food supplements market in ItalyNon-prescription drugs in ItalyPharmaceutical market in Italy
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.